Skip to main content

Table 3 HLA profiles of patients affected by BSS

From: Immunological features of patients affected by Barraquer-Simons syndrome

Patient

BSS1

A*01:01,*30:02

B*08:01,*18:01

C*05:01,*07:01

DRB1*03:01

DQB1*02:01

DQA1*05:01

DPB1*01:01,*02:02

BSS2

A*02:01,*11:01

B*35:01,*57:03/B*35:04,*57:01

C*04:01,*07:01

DRB1*11:03,*14:54

DQB1*03:01,*05:03

DQA1*01:04,*05:05/09

DPB1*04:01

BSS3

A*03:01,*11:01

B*27:05,*35:01

C*01:02,*04:01

DRB1*01:01,*04:03

DQB1*03:02,*05:01

DQA1*01:01,*03:01

DPB1*04:01

BSS4

A*02:01,*24:02

B*40:06,*49:01

C*07:01,*15:02

DRB1*01:01,*11:03

DQB1*03:01,*05:01

DQA1*01:01,*05:05/09

DPB1*02:01,*04:01

BSS5

A*03:01,*29:02

B*18:01,*44:02

C*05:01

DRB1*03:01,*11:01

DQB1*02:01,*03:01

DQA1*05:01,*05:05/09

DPB1*04:01

BSS6

A*11:01,*24:02

B*53:01,*57:01

C*04:01,*06:02

DRB1*07:01,*13:02

DQB1*03:03,*06:04

DQA1*01:02,*02:01

DPB1*03:01,*04:02

BSS7

A*29:02,*68:01

B*44:02,*49:01

C*07:01,*07:04

DRB1*04:01,*07:01

DQB1*02:02,*03:01

DQA1*02:01,*03:01

DPB1*04:01

BSS8

A*02:01,*24:02

B*15:01,*41:02

C*03:03,*17:01/17:03

DRB1*11:03,*13:03

DQB1*03:01

DQA1*05:05/09

DPB1*04:01,*04:02

BSS9

A*32:01,*68:01

B*35:08,*51:01

C*04:01,*15:02

DRB1*04:03,*13:01

DQB1*03:02,*06:03

DQA1*01:03,*03:01

DPB1*02:01,*04:01

BSS10

A*02:01,*24:02

B*15:01,*18:01

C*03:03,*12:03

DRB1*04:01,*11:04

DQB1*03:01,*03:02

DQA1*03:01,*05:05/09

n.s.

BSS11

A*02:01,*24:02

B*35:01,*45:01

C*04:01,*07:02

DRB1*11:01,*11:03

DQB1*03:01

DQA1*05:05/09

n.s.

BSS12

A*02:01

B*27:05,*39:06

C*02:02,*07:02

DRB1*08:01,*13:01

DQB1*04:02,*06:03

DQA1*01:03,*04:01

n.s.

BSS13

A*02:01,*11:01

B*44:02,*55:01

C*03:03,*05:01

DRB1*10:01,*16:01

DQB1*05:01,*05:02

DQA1*01:01/04/05,*01:02

n.s.

  1. The most likely HLA alleles at four-digit resolution, assigned as indicated in Materials and Methods, are displayed for each patient. Slashes represent ambiguities in the phenotype; n.s. not studied